InvestSMART

Optiscan Imaging Limited (ASX: OIL) - Announcements

Current share price for OIL : $0.150 0.005 (3.23%)+

ASX company news and announcements for Optiscan Imaging Limited (OIL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Optiscan Imaging Limited (OIL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Optiscan Imaging Limited (OIL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Optiscan Imaging Limited (OIL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$157 Application for quotation of securities - OIL 7 Jun 2023 8:25AM $0.085 $0.150 risen by 76.47%
$157 Entitlement Offer Timetable Update 30 May 2023 5:49PM $0.089 $0.150 risen by 68.54%
$157 Proposed issue of securities - OIL 30 May 2023 10:00AM $0.100 $0.150 risen by 50%
$157 Optiscan Entitlement Issue Prospectus 30 May 2023 10:00AM $0.100 $0.150 risen by 50%
$157 Optiscan Launches Entitlement Offer to Raise $16.7M 30 May 2023 9:59AM $0.100 $0.150 risen by 50%
$157 Trading Halt 26 May 2023 9:29AM $0.100 $0.150 risen by 50%
$157 Optiscan Oral Study Published in Prestigious Medical Journal 15 May 2023 9:03AM $0.087 $0.150 risen by 72.41%
$157 OIL March 2023 Quarterly Report and Appendix 4C 28 Apr 2023 10:39AM $0.090 $0.150 risen by 66.67%
$157 Change of Director's Interest Notice 21 Apr 2023 6:41PM $0.099 $0.150 risen by 51.52%
$157 Notification of cessation of securities - OIL 21 Apr 2023 6:34PM $0.099 $0.150 risen by 51.52%
$157 Optiscan Establishes US Commercial Operation in Minnesota 3 Apr 2023 10:08AM $0.100 $0.150 risen by 50%
$157 Change of Director's Interest Notice - K Borg 31 Mar 2023 8:02PM $0.100 $0.150 risen by 50%
$157 Change of Director's Interest Notice - R Cooke 30 Mar 2023 8:16AM $0.097 $0.150 risen by 54.64%
$157 Optiscan Platform Highly Accurate for Oral Cancer Diagnosis 14 Mar 2023 8:28AM $0.092 $0.150 risen by 63.04%
$157 Optiscan Intends to pursue De Novo Pathway for InVivage 2 Mar 2023 12:32PM $0.091 $0.150 risen by 64.84%
$157 OIL Appendix 4D and 31 December 2022 Half-year report 27 Feb 2023 12:57PM $0.099 $0.150 risen by 51.52%
$157 Optiscan partners with Prolucid to develop AI Algorithms 30 Jan 2023 8:46AM $0.125 $0.150 risen by 20%
$157 OIL December 2022 Quarterly Report and Appendix 4C 27 Jan 2023 3:22PM $0.125 $0.150 risen by 20%
$157 Section 708A Cleansing Notice 11 Jan 2023 6:58PM $0.100 $0.150 risen by 50%
$157 Application for quotation of securities - OIL 11 Jan 2023 6:54PM $0.100 $0.150 risen by 50%
$157 Change of Director's Interest Notice 12 Dec 2022 5:04PM $0.105 $0.150 risen by 42.86%
$157 Section 708A Cleansing Notice 8 Dec 2022 5:11PM $0.100 $0.150 risen by 50%
$157 Application for quotation of securities - OIL 8 Dec 2022 4:48PM $0.100 $0.150 risen by 50%
$157 Application for quotation of securities - OIL 8 Dec 2022 4:45PM $0.100 $0.150 risen by 50%
$157 Application for quotation of securities - OIL 8 Dec 2022 4:43PM $0.100 $0.150 risen by 50%

151 - 175 of 634 results

Page 7 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.